Investor Alert

Market Pulse Archives

Dec. 8, 2021, 11:08 a.m. EST · CORRECTED

Merck KGaA invests nearly $700 million into venture capital arm M Ventures

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Merck KGaA ADR (MKKGY)
  • X
    Merck KGaA (MRK)

or Cancel Already have a watchlist? Log In

By Steve Gelsi

This replaces an earlier item that incorrectly reported the company making the investment in M Ventures. It has been corrected.

Merck KGaA /zigman2/quotes/206962101/delayed MKKGY -0.08% /zigman2/quotes/209909728/delayed XE:MRK -0.19% said Wednesday it will invest an additional 600 million euros (about $680 million) into its corporate venture capital arm M Ventures over the next five years. That's the third increase in financial commitment announced by the Germany-based science and technology company since M Ventures' inception in 2009. "Over the past decade, M Ventures has established itself globally as a leading partner to the biotech and tech venture ecosystems," said Merck KGaA Chief Executive Belén Garijo.

US : U.S.: OTC
$ 32.31
-0.03 -0.08%
Volume: 50,930
Oct. 3, 2023 3:54p
P/E Ratio
Dividend Yield
Market Cap
$70.51 billion
Rev. per Employee
XE : Germany: Xetra
-0.30 -0.19%
Volume: 164,243
Oct. 3, 2023 6:30p
P/E Ratio
Dividend Yield
Market Cap
€67.17 billion
Rev. per Employee

Get news alerts on Merck KGaA ADR — or create your own.
This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.